|
OMIM |
Link |
Information gain |
01 |
|
IBGC1
|
[NCBI]
|
0.0166937
|
|
|
basal ganglia calcification, idiopathic, childhood-onset
|
[NCBI]
|
0.00754944
|
|
|
basal ganglia calcification, idiopathic, 2
|
[NCBI]
|
0.00319562
|
|
|
HFTC
|
[NCBI]
|
0.00285831
|
|
|
GACI
|
[NCBI]
|
0.0019565
|
|
|
singleton-merten syndrome
|
[NCBI]
|
0.00159232
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.0015144
|
|
|
AGS1
|
[NCBI]
|
0.00151393
|
|
|
folic acid, transport defect involving
|
[NCBI]
|
0.00149767
|
|
|
intestinal atresia, multiple
|
[NCBI]
|
0.00129807
|
|
|
PXE
|
[NCBI]
|
0.0010891
|
|
|
TNFRSF11B
|
[NCBI]
|
0.000870883
|
|
|
SPP1
|
[NCBI]
|
0.000798409
|
|
|
upington disease
|
[NCBI]
|
0.000794815
|
|
|
cardiomyopathy, fatal fetal, due to myocardial calcification
|
[NCBI]
|
0.000794815
|
|
|
PTH
|
[NCBI]
|
0.00078125
|
|
|
OPTB3
|
[NCBI]
|
0.000773353
|
|
|
GALNT3
|
[NCBI]
|
0.000579385
|
|
|
3-@hydroxyisobutyric aciduria
|
[NCBI]
|
0.000577852
|
|
|
RA
|
[NCBI]
|
0.000527653
|
|
|
SCA20
|
[NCBI]
|
0.000496582
|
|
|
testicular microlithiasis
|
[NCBI]
|
0.000496582
|
|
|
calcific aortic disease with immunologic abnormalities, familial
|
[NCBI]
|
0.000457573
|
|
|
MVP
|
[NCBI]
|
0.000436515
|
|
|
dentin dysplasia, type i
|
[NCBI]
|
0.000405426
|
|
|
apnea, obstructive sleep
|
[NCBI]
|
0.00039856
|
|
|
angioma, hereditary neurocutaneous
|
[NCBI]
|
0.000374765
|
|
|
gaucher disease, type iiic
|
[NCBI]
|
0.000371949
|
|
|
MNG1
|
[NCBI]
|
0.000349436
|
|
|
FGF23
|
[NCBI]
|
0.000345702
|
|
|
HHS
|
[NCBI]
|
0.000335053
|
|
|
aortic aneurysm, familial thoracic 1
|
[NCBI]
|
0.000309189
|
|
|
keutel syndrome
|
[NCBI]
|
0.000288635
|
|
|
kenny-caffey syndrome, type 2
|
[NCBI]
|
0.000277931
|
|
|
NFTC
|
[NCBI]
|
0.00027439
|
|
|
spondyloenchondrodysplasia
|
[NCBI]
|
0.000252498
|
|
|
RNS
|
[NCBI]
|
0.000236393
|
|
|
pulmonary alveolar microlithiasis
|
[NCBI]
|
0.00023075
|
|
|
tropical calcific pancreatitis
|
[NCBI]
|
0.000219955
|
|
|
PCTT
|
[NCBI]
|
0.000207261
|
|
|
ST8
|
[NCBI]
|
0.000204568
|
|
|
CF
|
[NCBI]
|
0.000199815
|
|
|
SPARC
|
[NCBI]
|
0.000191185
|
|
|
choroid plexus calcification and mental retardation
|
[NCBI]
|
0.000182875
|
|
|
encephalopathy with intracranial calcification, growth hormone deficiency, microcephaly, and retinal degeneration
|
[NCBI]
|
0.000182875
|
|
|
epilepsy with bilateral occipital calcifications
|
[NCBI]
|
0.000182875
|
|
|
CCAL2
|
[NCBI]
|
0.000176476
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
0.000175766
|
|
|
spondylometaepiphyseal dysplasia, short limb-hand type
|
[NCBI]
|
0.000151978
|
|
|
amyloidosis, cerebroarterial, hereditary, iowa type
|
[NCBI]
|
0.000151978
|
|
|
ossified ear cartilages with mental deficiency, muscle wasting, and bony changes
|
[NCBI]
|
0.000151978
|
|
|
ADM
|
[NCBI]
|
0.000134218
|
|
|
lipoid proteinosis of urbach and wiethe
|
[NCBI]
|
0.000126949
|
|
|
SAMD9
|
[NCBI]
|
0.000109476
|
|
|
TRS
|
[NCBI]
|
0.000105996
|
|
|
MGP
|
[NCBI]
|
0.000100912
|
|
|
BCNS
|
[NCBI]
|
0.000100879
|
|
|
OPLL
|
[NCBI]
|
9.88457e-05
|
|
|
ENPP1
|
[NCBI]
|
9.72502e-05
|
|
|
craniosynostosis, calcification of basal ganglia, and facial dysmorphism
|
[NCBI]
|
9.14121e-05
|
|
|
tracheopathia osteoplastica
|
[NCBI]
|
9.14121e-05
|
|
|
diabetes insipidus, nephrogenic, with mental retardation and intracerebral calcification
|
[NCBI]
|
9.14121e-05
|
|
|
vascular hyalinosis
|
[NCBI]
|
9.14121e-05
|
|
|
hypophosphatemia, renal, with intracerebral calcifications
|
[NCBI]
|
9.14121e-05
|
|
|
facial dysmorphism, selective tooth agenesis, and choroid calcification
|
[NCBI]
|
9.14121e-05
|
|
|
arthropathy, tendinous calcinosis, and progeroid features
|
[NCBI]
|
9.14121e-05
|
|
|
coracoclavicular joint, anomalous
|
[NCBI]
|
9.14121e-05
|
|
|
hyperparathyroidism, neonatal self-limited primary, with hypercalciuria
|
[NCBI]
|
9.14121e-05
|
|
|
wolman disease
|
[NCBI]
|
8.44909e-05
|
|
|
ossified ear cartilages
|
[NCBI]
|
6.89971e-05
|
|
|
AGS2
|
[NCBI]
|
6.89971e-05
|
|
|
revesz syndrome
|
[NCBI]
|
6.89971e-05
|
|
|
chondrocalcinosis due to apatite crystal deposition
|
[NCBI]
|
6.89971e-05
|
|
|
chondrodysplasia punctata syndrome
|
[NCBI]
|
6.89971e-05
|
|
|
ulna metaphyseal dysplasia syndrome
|
[NCBI]
|
6.89971e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
6.75738e-05
|
|
|
KL
|
[NCBI]
|
6.74642e-05
|
|
|
VEGF
|
[NCBI]
|
6.65953e-05
|
|
|
HHT
|
[NCBI]
|
6.51864e-05
|
|
|
GBA
|
[NCBI]
|
6.46391e-05
|
|
|
HRPT1
|
[NCBI]
|
6.4329e-05
|
|
|
CTHRC1
|
[NCBI]
|
6.41994e-05
|
|
|
thalamic degeneration, symmetric infantile
|
[NCBI]
|
6.05726e-05
|
|
|
arthrogryposis multiplex congenita with whistling face
|
[NCBI]
|
6.05726e-05
|
|
|
AD
|
[NCBI]
|
5.96466e-05
|
|
|
RCDP1
|
[NCBI]
|
5.87611e-05
|
|
|
CHBL
|
[NCBI]
|
5.51219e-05
|
|
|
haw river syndrome
|
[NCBI]
|
5.51219e-05
|
|
|
carotid intimal medial thickness 1
|
[NCBI]
|
5.51219e-05
|
|
|
PKDTS
|
[NCBI]
|
5.51219e-05
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
5.51219e-05
|
|
|
metachondromatosis
|
[NCBI]
|
5.51219e-05
|
|
|
BGLAP
|
[NCBI]
|
5.43791e-05
|
|
|
ABCC6
|
[NCBI]
|
5.33252e-05
|
|
|
MRX59
|
[NCBI]
|
5.10836e-05
|
|
|
RNASEH2B
|
[NCBI]
|
5.04342e-05
|
|
|
RNASEH2C
|
[NCBI]
|
5.04342e-05
|
|
|
pilomatrixoma
|
[NCBI]
|
4.78772e-05
|
|
|
MG
|
[NCBI]
|
4.63258e-05
|
|
|
ARNTL
|
[NCBI]
|
4.52483e-05
|
|
|
RNASEH2A
|
[NCBI]
|
4.52483e-05
|
|
|
renal tubular acidosis, proximal, with ocular abnormalities and mental retardation
|
[NCBI]
|
4.52204e-05
|
|
|
EKD1
|
[NCBI]
|
4.51097e-05
|
|
|
aortic valve disease
|
[NCBI]
|
4.45613e-05
|
|
|
carnitine palmitoyltransferase ii deficiency, lethal neonatal
|
[NCBI]
|
4.29543e-05
|
|
|
PBC
|
[NCBI]
|
4.29543e-05
|
|
|
SLC34A2
|
[NCBI]
|
4.1886e-05
|
|
|
HEY2
|
[NCBI]
|
4.1886e-05
|
|
|
AP1S2
|
[NCBI]
|
4.1886e-05
|
|
|
AHSG
|
[NCBI]
|
4.1886e-05
|
|
|
osseous heteroplasia, progressive
|
[NCBI]
|
4.09804e-05
|
|
|
EPHX2
|
[NCBI]
|
3.93899e-05
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
3.92331e-05
|
|
|
BPP
|
[NCBI]
|
3.92331e-05
|
|
|
EGF
|
[NCBI]
|
3.86152e-05
|
|
|
OSMED
|
[NCBI]
|
3.7667e-05
|
|
|
SLC22A6
|
[NCBI]
|
3.74038e-05
|
|
|
FOP
|
[NCBI]
|
3.64665e-05
|
|
|
gaucher disease, type i
|
[NCBI]
|
3.61057e-05
|
|
|
TREM2
|
[NCBI]
|
3.57548e-05
|
|
|
HOMG
|
[NCBI]
|
3.49542e-05
|
|
|
NSHPT
|
[NCBI]
|
3.49542e-05
|
|
|
HHS
|
[NCBI]
|
3.37637e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
3.37637e-05
|
|
|
LMNA
|
[NCBI]
|
3.34563e-05
|
|
|
ANKH
|
[NCBI]
|
3.20239e-05
|
|
|
TREX1
|
[NCBI]
|
3.20239e-05
|
|
|
dent disease 1
|
[NCBI]
|
3.16386e-05
|
|
|
marshall syndrome
|
[NCBI]
|
3.16386e-05
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
3.16386e-05
|
|
|
molybdenum cofactor deficiency
|
[NCBI]
|
3.16386e-05
|
|
|
DGI1
|
[NCBI]
|
3.16386e-05
|
|
|
CA2
|
[NCBI]
|
3.10437e-05
|
|
|
SLC6A6
|
[NCBI]
|
3.10437e-05
|
|
|
PPCD1
|
[NCBI]
|
2.9786e-05
|
|
|
CPT2
|
[NCBI]
|
2.93406e-05
|
|
|
CSF1
|
[NCBI]
|
2.85907e-05
|
|
|
CTSB
|
[NCBI]
|
2.85907e-05
|
|
|
PLOSL
|
[NCBI]
|
2.81467e-05
|
|
|
PALS
|
[NCBI]
|
2.73935e-05
|
|
|
EGFR
|
[NCBI]
|
2.64798e-05
|
|
|
LBR
|
[NCBI]
|
2.55353e-05
|
|
|
NOTCH1
|
[NCBI]
|
2.45458e-05
|
|
|
VWM
|
[NCBI]
|
2.41433e-05
|
|
|
PHA
|
[NCBI]
|
2.41433e-05
|
|
|
ACP5
|
[NCBI]
|
2.4024e-05
|
|
|
biotinidase deficiency
|
[NCBI]
|
2.30345e-05
|
|
|
BMP2
|
[NCBI]
|
2.28358e-05
|
|
|
phenylketonuria ii
|
[NCBI]
|
2.28358e-05
|
|
|
PDB
|
[NCBI]
|
2.25131e-05
|
|
|
alkaptonuria
|
[NCBI]
|
2.25131e-05
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
2.10636e-05
|
|
|
CTSC
|
[NCBI]
|
2.07514e-05
|
|
|
MMP3
|
[NCBI]
|
2.07514e-05
|
|
|
EFE
|
[NCBI]
|
2.06146e-05
|
|
|
MCOPS7
|
[NCBI]
|
2.06146e-05
|
|
|
CYP1A1
|
[NCBI]
|
2.01731e-05
|
|
|
TNF
|
[NCBI]
|
1.9846e-05
|
|
|
GAA
|
[NCBI]
|
1.95885e-05
|
|
|
ODDD
|
[NCBI]
|
1.93563e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
1.89636e-05
|
|
|
FIH
|
[NCBI]
|
1.89636e-05
|
|
|
UMOD
|
[NCBI]
|
1.88063e-05
|
|
|
KSS
|
[NCBI]
|
1.87335e-05
|
|
|
PRL
|
[NCBI]
|
1.82104e-05
|
|
|
PTHLH
|
[NCBI]
|
1.78857e-05
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
1.78562e-05
|
|
|
CNC1
|
[NCBI]
|
1.78562e-05
|
|
|
HHC1
|
[NCBI]
|
1.71708e-05
|
|
|
CALCRL
|
[NCBI]
|
1.70085e-05
|
|
|
melanoma, uveal
|
[NCBI]
|
1.53278e-05
|
|
|
TS
|
[NCBI]
|
1.45674e-05
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
1.45081e-05
|
|
|
STAT1
|
[NCBI]
|
1.41173e-05
|
|
|
CSA
|
[NCBI]
|
1.39938e-05
|
|
|
mucolipidosis ii
|
[NCBI]
|
1.32661e-05
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
1.23687e-05
|
|
|
MTTL1
|
[NCBI]
|
1.18816e-05
|
|
|
GNAS
|
[NCBI]
|
1.17744e-05
|
|
|
CRMO
|
[NCBI]
|
1.13492e-05
|
|
|
CLS
|
[NCBI]
|
1.13492e-05
|
|
|
CEACAM5
|
[NCBI]
|
1.13401e-05
|
|
|
hurler syndrome
|
[NCBI]
|
1.11575e-05
|
|
|
MUC1
|
[NCBI]
|
9.90554e-06
|
|
|
PLTP
|
[NCBI]
|
9.90426e-06
|
|
|
SLE
|
[NCBI]
|
9.53985e-06
|
|
|
HGPS
|
[NCBI]
|
9.43125e-06
|
|
|
SVAS
|
[NCBI]
|
8.39789e-06
|
|
|
AR
|
[NCBI]
|
7.86811e-06
|
|
|
AGER
|
[NCBI]
|
7.85762e-06
|
|
|
AVP
|
[NCBI]
|
7.40161e-06
|
|
|
SDS
|
[NCBI]
|
7.3593e-06
|
|
|
CD
|
[NCBI]
|
7.3536e-06
|
|
|
glycogen storage disease ii
|
[NCBI]
|
7.23888e-06
|
|
|
temporal arteritis
|
[NCBI]
|
7.18474e-06
|
|
|
SPINK1
|
[NCBI]
|
6.50468e-06
|
|
|
AHO
|
[NCBI]
|
6.3419e-06
|
|
|
APP
|
[NCBI]
|
6.31451e-06
|
|
|
OSM
|
[NCBI]
|
6.08556e-06
|
|
|
krabbe disease
|
[NCBI]
|
4.2987e-06
|
|
|
ALK
|
[NCBI]
|
4.28831e-06
|
|
|
phenylketonuria
|
[NCBI]
|
3.92923e-06
|
|
|
RB1
|
[NCBI]
|
3.81602e-06
|
|
|
LDLR
|
[NCBI]
|
3.81602e-06
|
|
|
CFTR
|
[NCBI]
|
3.79121e-06
|
|
|
GFAP
|
[NCBI]
|
3.4662e-06
|
|
|
IP
|
[NCBI]
|
3.35292e-06
|
|
|
LPL
|
[NCBI]
|
2.4951e-06
|
|
|
DRPLA
|
[NCBI]
|
2.43203e-06
|
|
|
EIG
|
[NCBI]
|
2.38453e-06
|
|
|
APOE
|
[NCBI]
|
2.13305e-06
|
|
|
BDNF
|
[NCBI]
|
2.09312e-06
|
|
|
VDR
|
[NCBI]
|
1.98773e-06
|
|
|
ALD
|
[NCBI]
|
1.63945e-06
|
|
|
CTGF
|
[NCBI]
|
1.4274e-06
|
|
|
leber optic atrophy
|
[NCBI]
|
1.21117e-06
|
|
|
ALB
|
[NCBI]
|
1.19231e-06
|
|
|
LAM
|
[NCBI]
|
1.18179e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
8.91286e-07
|
|
|
WBS
|
[NCBI]
|
8.64373e-07
|
|
|
PJS
|
[NCBI]
|
4.47926e-07
|
|
|
GIST
|
[NCBI]
|
1.18825e-07
|
|
|
MFS
|
[NCBI]
|
9.188e-08
|
|
|
PCNA
|
[NCBI]
|
2.52226e-08
|
|